12:00 AM
 | 
Jul 22, 2013
 |  BC Week In Review  |  Company News  |  Deals

Allon, Paladin deal

Paladin completed its acquisition of neurology company Allon for C$1 ($0.96) for all outstanding Allon shares,...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >